Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Biotherapeutics company announces strategic updates at investment meeting
April 7th, 2005
Genentech, Inc., (DNA) presented an overview of its strategy and financial goals for 2005 and beyond at its investment community meeting in New York City, New York. In addition, the company provided investors with an overview of recent developments, including highlights from its research, product development, and commercial and manufacturing efforts. Genentech's Chairman and CEO Arthur D. Levinson, PhD, and other senior company executives presented at the meeting. "We recently completed an outstanding year of growth in 2004 and are well positioned for growth in 2005 and beyond," said Levinson. "Scientific research is our foundation and our future. We...
Source: Women's Health Weekly (2005-04-07)
|
